Stock Market Today, June: Bio-Techne Surges on Merck Bid
A high-stakes cash bid from Merck KGaA sent Bio-Techne stock higher and sparked a flurry of trading. Here’s what inve...
On this Biotech M&A tag page, you'll find coverage from 3 articles on Lilly, AbbVie, and other biotechs. See how deal activity could reshape stock moves and your financial planning.
7 articlesA high-stakes cash bid from Merck KGaA sent Bio-Techne stock higher and sparked a flurry of trading. Here’s what inve...
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
AbbVie stock jumped today after the company disclosed a bold acquisition of Apogee Therapeutics for $10.9 billion. Th...
A major biotech takeover bid sets the tone for today’s market. AbbVie’s cash offer for Apogee Therapeutics sent share...
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Eli Lilly is shaking up its growth plan by expanding beyond obesity with new infectious disease initiatives. This art...
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...